Abstract
Governments worldwide are increasingly concerned about the booming use of CBD (cannabidiol) products. However, we know little about the impact of their liberalization. We study a unique case of unintended liberalization of a CBD-based product (light cannabis) that occurred in Italy in 2017. Using unique and high-frequency data on prescription drug sales and by exploiting the staggered local availability of the new product in each Italian province, we document a significant substitution effect between light cannabis and anxiolytics, sedatives, opioids, anti-depressants and anti-psychotics. Results are informative for regulators and suggest that bans on light cannabis use would disregard the needs of patients to seek effective reliefs of their symptoms.
Highlights
The cannabis market has gained momentum worldwide
With the 2018 Farm Bill, hemp was removed from the definition of marijuana of the Controlled Substances Act and similar products have become available in the US as well, where this industry is expected to be worth $20 billion by 2024 (BDS Analytics)
The dependent variable is expressed in logs. This allows us to interpret the DID-coefficient as the average percentage change in the monthly number of dispensed drugs resulting from the local availability of light cannabis
Summary
Ranging from recreational and medical marijuana to cannabis-derived products- such as CBD (cannabidiol), a relaxant compound of cannabis- its consumption is booming around the World. Low-strength versions of cannabis such as hemp (or industrial hemp), rich in CBD, have become widely popular and sold in the form of herbal cannabis (referred to as light cannabis, hereafter), lotions, extracts and candies. A major case of interest is Italy, a country with a conservative view on cannabis, but in which “light cannabis shops” unexpectedly blossomed due to a loophole in the legislation and received massive media and political attention.. With the 2018 Farm Bill, hemp was removed from the definition of marijuana of the Controlled Substances Act and similar products have become available in the US as well, where this industry is expected to be worth $20 billion by 2024 (BDS Analytics) A major case of interest is Italy, a country with a conservative view on cannabis, but in which “light cannabis shops” unexpectedly blossomed due to a loophole in the legislation and received massive media and political attention. With the 2018 Farm Bill, hemp was removed from the definition of marijuana of the Controlled Substances Act and similar products have become available in the US as well, where this industry is expected to be worth $20 billion by 2024 (BDS Analytics)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
